BRYNELSEN CHARLES 4
4 · Envoy Medical, Inc. · Filed Dec 5, 2025
Insider Transaction Report
Form 4
BRYNELSEN CHARLES
Director
Transactions
- Award
Stock Option (right to buy)
2025-12-03+62,500→ 62,500 totalExercise: $0.81From: 2026-05-01Exp: 2035-12-03→ Class A Common Stock (62,500 underlying)
Holdings
- 50,000
Class A Common Stock
- 62,500
Stock Option (right to buy)
Exercise: $2.40Exp: 2033-10-15→ Class A Common Stock (62,500 underlying)
Footnotes (1)
- [F1]Options to purchase 46,875 shares vest on 10/15/2023, and the remaining 15,625 shares vest pro rata on the 15th of each month thereafter for 36 consecutive months.